Linical Co

Linical Co EBIT per Share

The EBIT per Share of Linical Co (2183.T) as of Nov 9, 2026 is -91.78 JPY. In the previous year, EBIT per Share was -25.83 JPY — a change of 255.28% (lower).

EBIT per Share

-91.78JPY

YoY

255.28%

Last updated:

EBIT per Share of Linical Co is 2026 -91.78 JPY. EBIT per Share of Linical Co was 2025 -25.83 JPY. It decreases by 255.28% lower compared to the previous year.

The Linical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
44.51 JPY
Jan 1, 2021
20.08 JPY
Jan 1, 2022
48.08 JPY
Jan 1, 2023
55.64 JPY
Jan 1, 2024
32.13 JPY
Jan 1, 2025
-25.83 JPY
Jan 1, 2026
-91.78 JPY
Jan 1, 2027 (e)
37.87 JPY
The Linical Co EBIT per Share history
YEAREBIT per ShareYoY
est37.87JPY-141.25%
-91.78JPY+255.28%
-25.83JPY-180.40%
32.13JPY-42.25%
55.64JPY+15.73%
48.08JPY+139.48%
20.08JPY-54.89%
44.51JPY-17.13%
53.70JPY-34.32%
81.76JPY-12.71%
93.67JPY+5.94%
88.42JPY+129.69%
38.49JPY+24.27%
30.98JPY-29.62%
44.02JPY+37.66%
31.98JPY+152.25%
12.68JPY-42.78%
22.15JPY-0.37%
22.24JPY+8.71%
20.45JPY+148.37%
8.24JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

EBIT per Share of Linical Co is -91.78 JPY in 2026.

EBIT per Share of Linical Co changed from -25.83 JPY to -91.78 JPY, representing a 255.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Linical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Linical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Linical Co